Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. PE Ratio 2012–2026
Current and historical P/E ratio for Supernus Pharmaceuticals Inc. (SUPN), calculated by dividing the latest closing price by the trailing twelve-month earnings per share (EPS). As of September 30, 2025 it is 597.38.
From: 06/30/2012To: 03/31/2026
Stock Price
TTM Net EPS
PE Ratio
Supernus Pharmaceuticals Inc. PE Ratio — FAQ
Supernus Pharmaceuticals Inc. (SUPN) pe ratio over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's pe ratio history?
The chart and table above show Supernus Pharmaceuticals Inc.'s pe ratio by year and by quarter, including the growth rate.